📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Downregulation of myostatin pathway in neuromuscular diseases may explain challenges of anti-myostatin therapeutic approaches. (2017)

First Author: Mariot V
Attributed to:  MICA: MRC Centre for Neuromuscular Diseases funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-017-01486-4

PubMed Identifier: 29192144

Publication URI: http://europepmc.org/abstract/MED/29192144

Type: Journal Article/Review

Volume: 8

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723